Compare Sinar Eka Selaras Tbk. (ERAL) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sinar Eka Selaras Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Sinar Eka Selaras Tbk. trades at Rp284 (market cap 1.47T, 501.8K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Sinar Eka Selaras Tbk. is far larger — about 2.5× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (817.3K versus 501.8K). Which is the better fit depends on your goals.
| ERAL | LABS | |
|---|---|---|
Market Cap | 1.47T | 584.6B |
Volume | 501.8K | 817.3K |
Lot | 5.02K | 8.17K |
Turnover | 141.93M | 120.01M |
Average Price | 282.83 | 146.84 |
Value | 141.93M | 120.01M |
Indicative Equilibrium Price | 284 | 146 |
Indicative Equilibrium Volume | 10 | 59 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sinar Eka Selaras Tbk.
PT Sinar Eka Selaras Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 12 of Myra Yuwono, S.H., dated March 13, 2009. PT Erajaya Swasembada Tbk, an entity incorporated in Indonesia, is the parent company of the Company. PT Eralink International, an entity incorporated inIndonesia, is the ultimate parent of the Company.
Read more on ERAL →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
